BNAI

BEN is, by its own admission, a development-stage company that has 'not generated any significant revenue to date' and has 'not yet sold any of our products beyond their pilot stage.' The numbers confirm it: FY2025 revenue of just $275K against an operating loss of $12.6M — an operating margin of -4,589% — while carrying a $55.6M accumulated deficit. At $17.19 the market is paying 366x sales for a company whose entire annual revenue wouldn't cover a single mid-level engineer's fully-loaded cost. There is no fundamental support for this valuation; the equity value rests entirely on a story about conversational-AI patents in automotive and healthcare that has yet to convert into commercial traction.

The balance sheet turns a speculative story into an existential one. Cash and equivalents are $172K against $10.8M of current liabilities and operating cash burn of -$5.09M a year. That is not months of runway — it is weeks — and management flags directly that it 'may need additional capital' with no assurance financing will be 'available on favorable terms, or at all,' plus a standalone liquidity risk factor. With no effective registration statement beyond an S-8 and S-4, the near-certain path is dilutive emergency financing. Note the share count collapsed 86% YoY to 5.86M (a reverse split, the classic Nasdaq listing-compliance maneuver), and the risk factors openly warn that insiders bought in 'below the current trading price' and that future resales 'may cause the market price to drop significantly.' The $17 print is a low-float, post-reverse-split artifact, not a considered valuation.